Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

Childhood Cancer Clinical Trial

Official title:

Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00579293
• Other study ID #: 04-098
• Status: Completed
• Phase: N/A
• First received: December 20, 2007
• Last updated: July 24, 2008
• Start date: August 2004
• Est. completion date: July 2008

Study information

• Verified date: July 2008
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.

Description:

To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: July 2008
• Est. primary completion date: July 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 49 Years

Eligibility

Inclusion Criteria:

• Currently at least 18 years of age and not older than 49 years of age

• Diagnosed with first malignancy before the age of 22

• Completed all cancer treatment at least three years prior

• Able to complete the survey instruments in English

• Scheduled for a routine off-treatment follow-up oncology appointment

• Currently disease-free and not receiving any cancer treatment

Exclusion Criteria:

• History of a central nervous system tumor

• A sensory or cognitive impairment that would interfere with completion of the survey

• Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Childhood Cancer

Locations

Country	Name	City	State
United States	Memorial Sloan-Kettering Cancer Center	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center

Country where clinical trial is conducted

United States, 

External Links

•   Memorial Sloan-Kettering Cancer Center